• Je něco špatně v tomto záznamu ?

Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012

Gent M van, CJ Heuvelman, der Heide HG van, HO Hallander, A Advani, N Guiso, von Konig CH Wirsing, DF Vestrheim, T Dalby, NK Fry, D Pierard, L Detemmerman, J Zavadilova, K Fabianova, C Logan, A Habington, M Byrne, A Lutynska, E Mosiej, C Pelaz, K...

. 2015 ; 34 (4) : 821-830.

Jazyk angličtina Země Německo

Perzistentní odkaz   https://www.medvik.cz/link/bmc18039852

Grantová podpora
NT14058 MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek
Zdroj

E-zdroje Online Plný text

NLK ProQuest Central od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-01-01 do Před 1 rokem

Odkazy

PubMed 25527446
DOI 10.1007/s10096-014-2297-2
Knihovny.cz E-zdroje

Despite more than 50 years of vaccination, pertussis is still an endemic disease, with regular epidemic outbreaks. With the exception of Poland, European countries have replaced whole-cell vaccines (WCVs) by acellular vaccines (ACVs) in the 1990s. Worldwide, antigenic divergence in vaccine antigens has been found between vaccine strains and circulating strains. In this work, 466 Bordetella pertussis isolates collected in the period 1998-2012 from 13 European countries were characterised by multi-locus antigen sequence typing (MAST) of the pertussis toxin promoter (ptxP) and of the genes coding for proteins used in the ACVs: pertussis toxin (Ptx), pertactin (Prn), type 2 fimbriae (Fim2) and type 3 fimbriae (Fim3). Isolates were further characterised by fimbrial serotyping, multi-locus variable-number tandem repeat analysis (MLVA) and pulsed-field gel electrophoresis (PFGE). The results showed a very similar B. pertussis population for 12 countries using ACVs, while Poland, which uses a WCV, was quite distinct, suggesting that ACVs and WCVs select for different B. pertussis populations. This study forms a baseline for future studies on the effect of vaccination programmes on B. pertussis populations.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18039852
003      
CZ-PrNML
005      
20181207150226.0
007      
ta
008      
181207s2015 gw f 000 0|eng||
009      
AR
024    0_
$a 10.1007/s10096-014-2297-2 $2 doi
035    __
$a (PubMed)25527446
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a van Gent M $u van Gent, M. Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, The Netherlands, marjolein.van.gent@rivm.nl.
245    10
$a Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012 / $c Gent M van, CJ Heuvelman, der Heide HG van, HO Hallander, A Advani, N Guiso, von Konig CH Wirsing, DF Vestrheim, T Dalby, NK Fry, D Pierard, L Detemmerman, J Zavadilova, K Fabianova, C Logan, A Habington, M Byrne, A Lutynska, E Mosiej, C Pelaz, K Grondahl-Yli-Hannuksela, AM Barkoff, J Mertsola, A Economopoulou, Q He, FR Mooi
520    9_
$a Despite more than 50 years of vaccination, pertussis is still an endemic disease, with regular epidemic outbreaks. With the exception of Poland, European countries have replaced whole-cell vaccines (WCVs) by acellular vaccines (ACVs) in the 1990s. Worldwide, antigenic divergence in vaccine antigens has been found between vaccine strains and circulating strains. In this work, 466 Bordetella pertussis isolates collected in the period 1998-2012 from 13 European countries were characterised by multi-locus antigen sequence typing (MAST) of the pertussis toxin promoter (ptxP) and of the genes coding for proteins used in the ACVs: pertussis toxin (Ptx), pertactin (Prn), type 2 fimbriae (Fim2) and type 3 fimbriae (Fim3). Isolates were further characterised by fimbrial serotyping, multi-locus variable-number tandem repeat analysis (MLVA) and pulsed-field gel electrophoresis (PFGE). The results showed a very similar B. pertussis population for 12 countries using ACVs, while Poland, which uses a WCV, was quite distinct, suggesting that ACVs and WCVs select for different B. pertussis populations. This study forms a baseline for future studies on the effect of vaccination programmes on B. pertussis populations.
590    __
$a bohemika - dle Pubmed
650    02
$a antigeny bakteriální $x genetika $7 D000942
650    02
$a Bordetella pertussis $x genetika $x izolace a purifikace $x klasifikace $7 D001886
650    02
$a pulzní gelová elektroforéza $7 D016521
650    12
$a genetická variace $7 D014644
650    02
$a lidé $7 D006801
650    02
$a minisatelitní repetice $7 D018598
650    02
$a molekulární epidemiologie $7 D017720
650    02
$a multilokusová sekvenční typizace $7 D058885
650    02
$a pertusový toxin $x genetika $7 D037342
650    02
$a promotorové oblasti (genetika) $7 D011401
650    02
$a sérotypizace $7 D012703
650    12
$a pertuse $x epidemiologie $x mikrobiologie $7 D014917
651    _2
$a Evropa $x epidemiologie $7 D005060
700    1_
$a Heuvelman CJ
700    1_
$a van der Heide HG
700    1_
$a Hallander HO
700    1_
$a Advani A
700    1_
$a Guiso N
700    1_
$a Wirsing von Konig CH
700    1_
$a Vestrheim DF
700    1_
$a Dalby T
700    1_
$a Fry NK
700    1_
$a Pierard D
700    1_
$a Detemmerman L
700    1_
$a Zavadilová, Jana $7 xx0230892
700    1_
$a Fabiánová, Kateřina $7 xx0105124
700    1_
$a Logan C
700    1_
$a Habington A
700    1_
$a Byrne M
700    1_
$a Lutynska A
700    1_
$a Mosiej E
700    1_
$a Pelaz C
700    1_
$a Grondahl-Yli-Hannuksela K
700    1_
$a Barkoff AM
700    1_
$a Mertsola J
700    1_
$a Economopoulou A
700    1_
$a He Q
700    1_
$a Mooi FR
773    0_
$t European Journal of Clinical Microbiology & Infectious Diseases $g Roč. 34, č. 4 (2015), s. 821-830 $p Eur J Clin Microbiol Infect Dis $x 0934-9723 $w MED00001612
773    0_
$p Eur J Clin Microbiol Infect Dis $g 34(4):821-30, 2015 Apr
910    __
$a ABA008 $y 4 $z 0
990    __
$a 20181207150344 $b ABA008
991    __
$a 20181207150344 $b ABA008
999    __
$a ok $b bmc $g 1357197 $s 1036914
BAS    __
$a 3
BMC    __
$a 2015 $b 34 $c 4 $d 821-830 $x MED00001612 $i 0934-9723 $m European journal of clinical microbiology & infectious diseases
GRA    __
$a NT14058 $p MZ0
LZP    __
$a NLK 2018/lp

Najít záznam

Citační ukazatele

Možnosti archivace